Lowe G, Lee A, Rumley A, Price J, Fowkes F. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery study. Br J Haematol. 1997;96:168–73.

Article  CAS  PubMed  Google Scholar 

Irace C, Carallo C, Scavelli F, De Franceschi MS, Esposito T, Gnasso A. Blood viscosity in subjects with normoglycemia and prediabetes. Diabetes Care. 2014;37:488–92.

Article  CAS  PubMed  Google Scholar 

Marini MA, Fiorentino TV, Andreozzi F, Mannino GC, Perticone M, Sciacqua A, et al. Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity. Acta Diabetol. 2017;54:775–84.

Article  CAS  PubMed  Google Scholar 

Høieggen A, Fossum E, Moan A, Enger E, Kjeldsen SE. Whole-blood viscosity and the insulin-resistance syndrome. J Hypertens. 1998;16:203–10.

Article  PubMed  Google Scholar 

Marini MA, Fiorentino TV, Andreozzi F, Mannino GC, Succurro E, Sciacqua A, Mannino GC, Succurro E, Sciacqua A, et al. Hemorheological alterations in adults with prediabetes identified by hemoglobin A1c levels. Nutr Metab Cardiovasc Dis. 2017;27:601–8.

Article  CAS  PubMed  Google Scholar 

Sloop GD, Garber DW. The effects of low-density lipoprotein and high-density lipoprotein on blood viscosity correlate with their association with risk of atherosclerosis in humans. Clin Sci (Lond). 1997;92:473–9.

Article  CAS  PubMed  Google Scholar 

Letcher RL, Chien S, Pickering TG, Laragh JH. Elevated blood viscosity in patients with borderline essential hypertension. Hypertension. 1983;5:757–62.

Article  CAS  PubMed  Google Scholar 

Ciuffetti G, Schillaci G, Lombardini R, Pirro M, Vaudo G, Mannarino E. Prognostic impact of low-shear whole blood viscosity in hypertensive men. Eur J Clin Investig. 2005;35:93–8.

Article  CAS  Google Scholar 

Rillaerts E, van Gaal L, Xiang DZ, Vansant G, De Leeuw I. Blood viscosity in human obesity: relation to glucose tolerance and insulin status. Int J Obes (Lond). 1989;13:739–45.

CAS  Google Scholar 

de Simone G, Devereux RB, Chien S, Alderman MH, Atlas SA, Laragh JH. Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation. 1990;81:107–17.

Article  PubMed  Google Scholar 

Devereux RB, Drayer JI, Chien S, Pickering TG, Letcher RL, DeYoung JL, et al. Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension. Am J Cardiol. 1984;54:592–5.

Article  CAS  PubMed  Google Scholar 

Zannad F, Voisin P, Brunotte F, Bruntz JF, Stoltz JF, Gilgenkrantz JM. Haemorheological abnormalities in arterial hypertension and their relation to cardiac hypertrophy. J Hypertens. 1988;6:293–7.

Article  CAS  PubMed  Google Scholar 

Lee AJ, Mowbray PI, Lowe GD, Rumley A, Fowkes FG, Allan PL. Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh artery study. Circulation. 1998;97:1467–73.

Article  CAS  PubMed  Google Scholar 

Tripolino C, Irace C, Carallo C, De Franceschi MS, Scavelli F, Della Valle E, et al. Association between blood viscosity and common carotid artery elasticity. Clin Hemorheol Microcirc. 2016;62:55–62.

Article  PubMed  Google Scholar 

Riccio A, Cefalo CMA, Mazzanti C, Vero L, Fiorentino TV, Massimino M, et al. Whole blood viscosity is associated with reduced myocardial mechano-energetic efficiency in nondiabetic individuals. Eur J Clin Investig. 2024;54(3): e14127.

Article  CAS  Google Scholar 

Lowe G, Rumley A, Norrie J, Ford I, Shepherd J, Cobbe S, et al. Blood rheology, cardiovascular risk factors, and cardiovascular disease: the west of Scotland coronary prevention study. Thromb Haemost. 2000;84:553–8.

Article  CAS  PubMed  Google Scholar 

Tohgi H, Yamanouchi H, Murakami M, Kameyama M. Importance of the hematocrit as a risk factor in cerebral infarction. Stroke. 1978;9:369–74.

Article  CAS  PubMed  Google Scholar 

Woodward M, Lowe GD, Campbell DJ, Colman S, Rumley A, Chalmers J, et al. Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke. 2005;36:2143–7.

Article  PubMed  Google Scholar 

Neumann FJ, Katus HA, Hoberg E, Roebruck P, Braun M, Haupt HM, et al. Increased plasma viscosity and erythrocyte aggregation: indicators of an unfavourable clinical outcome in patients with unstable angina pectoris. Br Heart J. 1991;66:425–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Erikssen G, Thaulow E, Sandvik L, Stormorken H, Erikssen J. Haematocrit: A predictor of cardiovascular mortality? J Intern Med. 1993;234:493–9.

Article  CAS  PubMed  Google Scholar 

Danesh J, Collins R, Peto R, Lowe GD. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J. 2000;21:515–20.

Article  CAS  PubMed  Google Scholar 

Succurro E, Pedace E, Andreozzi F, Papa A, Vizza P, Fiorentino TV, et al. Reduction in global myocardial glucose metabolism in subjects with 1-hour postload hyperglycemia and impaired glucose tolerance. Diabetes Care. 2020;43:669–76.

Article  CAS  PubMed  Google Scholar 

Ohtake T, Yokoyama I, Watanabe T, Momose T, Serezawa T, Nishikawa J, et al. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET. J Nucl Med. 1995;36:456–63.

CAS  PubMed  Google Scholar 

Hu L, Qiu C, Wang X, Shao X, Wang Y. The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based 18F-FDG PET/CT study. BMC Cardiovasc Disord. 2018;18:203.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nielsen R, Jorsal A, Iversen P, Tolbod L, Bouchelouche K, Sørensen J, et al. Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolism. J Nucl Cardiol. 2018;25:169–76.

Article  PubMed  Google Scholar 

Succurro E, Vizza P, Papa A, Cicone F, Monea G, Tradigo G, et al. Metabolic syndrome is associated with impaired insulin-stimulated myocardial glucose metabolic rate in individuals with type 2 diabetes: a cardiac dynamic 18 F-FDG-PET study. Front Cardiovasc Med. 2022;9: 924787.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iozzo P, Chareonthaitawee P, Dutka D, Betteridge DJ, Ferrannini E, Camici PG. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes. 2002;51:3020–4.

Article  CAS  PubMed  Google Scholar 

Devesa A, Fuster V, Vazirani R, García-Lunar I, Oliva B, España S, et al. Cardiac insulin resistance in subjects with metabolic syndrome traits and early subclinical atherosclerosis. Diabetes Care. 2023;46:2050–7.

Article  PubMed  PubMed Central  Google Scholar 

Succurro E, Cicone F, Papa A, Miceli S, Vizza P, Fiorentino TV, et al. Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance. Cardiovasc Diabetol. 2023;22:4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang K, Lin J, Ji X, Lin T, Sun D, Zheng X, et al. Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis. J Nucl Cardiol. 2021;28:610–20.

Article  PubMed  Google Scholar 

Moan A, Nordby G, Os I, Birkeland KI, Kjeldsen SE. Relationship between hemorrheologic factors and insulin sensitivity in healthy young men. Metabolism. 1994;43:423–7.

Article  CAS  PubMed